I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 6 studies | 26% ± 7% | |
| adipocyte | 5 studies | 27% ± 10% | |
| oligodendrocyte | 5 studies | 20% ± 3% | |
| astrocyte | 4 studies | 24% ± 5% | |
| microglial cell | 4 studies | 21% ± 4% | |
| endothelial cell | 4 studies | 21% ± 2% | |
| cardiac muscle cell | 3 studies | 24% ± 6% | |
| T cell | 3 studies | 18% ± 3% | |
| mast cell | 3 studies | 19% ± 1% | |
| GABAergic neuron | 3 studies | 44% ± 14% | |
| glutamatergic neuron | 3 studies | 52% ± 19% | |
| oligodendrocyte precursor cell | 3 studies | 21% ± 1% | |
| dendritic cell | 3 studies | 22% ± 7% | |
| fibroblast | 3 studies | 20% ± 3% | |
| macrophage | 3 studies | 22% ± 2% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 16% ± 1% | |
| plasmacytoid dendritic cell | 3 studies | 19% ± 3% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 17% ± 2% |
